PHILADELPHIA — An oral, nonaddictive sodium channel blocker safely relieved moderate to severe acute pain after surgery, according to phase III data that could support regulatory…
Photo: Rattankun As previously mentioned, a common theme of the 2024 AAOMS Annual Meeting included a key focus on non-opioid options for acute pain management. Although…
A new, investigational NaV1.8 sodium channel blocker known as VX-548 reduced acute pain after abdominoplasty or pneumonectomy at the highest dose, but not at lower doses,…
